Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omacor (omega-3-acid ethyl ester 90) and cardiovascular risk factors in HIV patients on HAART
2005-005135-10Phase 4Completed
- Sponsor
- Jeppe Hagstrup Christensen
- Start
- Nov 2005
- Modality
- Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4 trial of omega-3-acid triglycerides in human immunodeficiency virus infection (HIV), hypertriglyceridemia and dyslipidemia, sponsored by Jeppe Hagstrup Christensen. Primary endpoint: Plasma triglycerides. Started Nov 2005; status: completed.
02
Drugs
omega-3-acid triglycerides
03
Conditions
human immunodeficiency virus infection (HIV)hypertriglyceridemiadyslipidemia
Beyond the preview
Go deeper on 2005-005135-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005135-10.